Society of Vascular and Interventional Neurology / X
Jul 2, 2025, 16:51
Research Tuesday from SVIN: IV Thrombolysis in Cervical Artery Dissection—A Safer Path Home?
Society of Vascular and Interventional Neurology (SVIN) recentlyy posted on X:
”Research Tuesday: Retrospective study by Shu and Shadi Yaghi et al found that use of IV thrombolysis in cervical artery dissection related stroke improved odds of home DC without increased risk of ICH. Skim With SVIN”
Read the article from Journal of the American Heart Association here.
In a compelling retrospective study Shu, Shadi Yaghi, and colleagues evaluated outcomes of intravenous thrombolysis in patients with stroke due to cervical artery dissection.
Their findings reveal that IV thrombolysis significantly improves the odds of discharge to home without an associated increase in the risk of intracerebral hemorrhage (ICH).
These results offer important reassurance regarding the safety and functional benefit of thrombolysis in this unique stroke subtype—potentially reshaping decision-making in acute management.
Find more research breakthroughs in Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning